SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-12-003568
Filing Date
2012-03-29
Accepted
2012-03-29 16:25:59
Documents
5
Period of Report
2012-05-08
Effectiveness Date
2012-03-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2208454zdef14a.htm DEF 14A 444022
2 G449652.JPG g449652.jpg GRAPHIC 10538
3 G270297.JPG g270297.jpg GRAPHIC 1927
4 G78922BCI001.GIF g78922bci001.gif GRAPHIC 41323
5 G78922BCI002.GIF g78922bci002.gif GRAPHIC 48766
  Complete submission text file 0001047469-12-003568.txt   586962
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34637 | Film No.: 12724291
SIC: 2834 Pharmaceutical Preparations